Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01959490
Title Trastuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Case Comprehensive Cancer Center

breast adenocarcinoma


Bevacizumab + Cyclophosphamide + Doxorubicin + Paclitaxel

Carboplatin + Docetaxel + Trastuzumab

Age Groups: adult
Covered Countries USA

No variant requirements are available.